Fast, accurate and cheap synthesis of ultralong strands of DNA is an essential foundation for synthetic DNA technologies such as cellular programming and engineering.
A team of Stanford engineers has identified first-in-class epidermal growth factor (EGF) mutants with enhanced activity. These mutants can stimulate increased EGF receptor activation at 10-fold lower concentrations than wild-type EGF.
Stanford researchers from the Khuri-Yakub group have designed an improved, high spatial resolution ultrasonic neuromodulation device that implements chip waveform instead of continuous wave PIRF.
Stanford researchers developed a new technology that prints networks with distinct branch structures that emulate the natural branching observed in in vivo vascular networks.
Metagenomic sequencing offers a powerful approach for the comprehensive monitoring and detection of pathogenic bacteria in food, clinical samples, and the environment.
Mouse embryonic stem (ES) cells are used for generating knockout and knockin mouse models, which are crucial for biomedical research as well as pre-clinical studies.
Stanford researchers have developed a device that combines one-photon and two-photon microscopy using fast temporal multiplexing enabling 3D alignment between in vivo and ex vivo data for neuroscience and spatial biology applications.
Stanford inventors have identified a treatment regimen that allows expansion of cardiomyocytes (CMs) derived from human induced pluripotent stem cells in vitro.
Adeno-associated virus (AAV) vectored products are currently leading candidates for gene therapy applications with multiple approved products and many more in clinical trials.